Pharmacovigilance in special populations: geriatric patients

2022-02-17T15:54:50+01:0010 December 2019|Senza categoria|

Special Populations are categories of patients that differ in age or in specific disorders. Consequently, the pharmacovigilance activity is more complex in their cases. It was discussed at the third edition of the European Pharmacovigilance Congress. Here is what Giovanni Furlan, Head of security risk, Director of Pfizer, reported on geriatric patients.

Go to Top